(Q36034668)

11 August 2017

1 reference

title

Serotonergic and dopaminergic systems in anorexia nervosa: a role for atypical antipsychotics? (English)

1 reference

11 August 2017

0 references

1 reference

Peter Bosanac

1

1 reference

11 August 2017

Trevor Norman

series ordinal

2

1 reference

11 August 2017

Graham Burrows

series ordinal

3

1 reference

11 August 2017

Peter Beumont

series ordinal

4

1 reference

11 August 2017

publication date

1 March 2005

1 reference

Australian and New Zealand Journal of Psychiatry

11 August 2017

published in

1 reference

11 August 2017

volume

39

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

146-153

1 reference

Comorbidity and outcome in eating disorders

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Anorexia nervosa and anorexic-like syndromes in a population-based female twin sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Increasing incidence of anorexia nervosa in the female population of northeast Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Evaluating recovery from anorexia nervosa and bulimia nervosa: integrating lessons learned from research and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

How well are 'cured' anorexia nervosa patients? An investigation of 16 weight-recovered anorexic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Australian and New Zealand clinical practice guidelines for the treatment of anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Drug therapy for patients with eating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Cholecystokinin-dopamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Effects of long-term treatment with antipsychotics on serum leptin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

21 January 2018

Serotonin and appetite

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Toward a unified theory of serotonin dysregulation in eating and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Altered serotonin activity in anorexia nervosa after long-term weight restoration. Does elevated cerebrospinal fluid 5-hydroxyindoleacetic acid level correlate with rigid and obsessive behavior?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Oestrogen and mental state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Evidence from a Canadian community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

"Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Brain dopamine is associated with eating behaviors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

The effects of a dopamine antagonist on luteinizing hormone and prolactin release in women with anorexia nervosa and in normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Case study: anorexia nervosa and autistic disorder in an adolescent girl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Olanzapine in the treatment of anorexia nervosa: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Factorial invariance across gender for the primary symptom dimensions of the SCL-90

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Estimating readiness for change in anorexia nervosa: comparing clients, clinicians, and research assessors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

Enhancing motivation for change in treatment-resistant eating disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1614.2005.01536.X

10.1111/J.1440-1614.2005.01536.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference